Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2a first-in-human study of ExPEC10V in older adults with prior urinary tract infection
NL-OMON52538Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2020
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of ExPEC10V, sponsored by Janssen Pharmaceutical. Started Oct 2020; status: completed.
02
Drugs
ExPEC10V
Beyond the preview
Go deeper on NL-OMON52538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52538.